Abstract
Aim:
To establish an efficient culture system to support embryonic stem (ES) cell differentiation into hepatocytes that coexpress F-VIII and F-IX.
Methods:
Mouse E14 ES cells were cultured in differentiation medium containing sodium butyrate (SB), basic fibroblast growth factor (bFGF), and/or bone morphogenetic protein 4 (BMP4) to induce the differentiation of endoderm cells and hepatic progenitor cells. Hepatocyte growth factor, oncostatin M, and dexamethasone were then used to induce the maturation of ES cell–derived hepatocytes. The mRNA expression levels of endoderm-specific genes and hepatocyte-specific genes, including the levels of F-VIII and F-IX, were detected by RT-PCR and real-time PCR during various stages of differentiation. Protein expression was examined by immunofluorescence and Western blot. At the final stage of differentiation, flow cytometry was performed to determine the percentage of cells coexpressing F-VIII and F-IX, and ELISA was used to detect the levels of F-VIII and F-IX protein secreted into the culture medium.
Results:
The expression of endoderm-specific and hepatocyte-specific markers was upregulated to highest level in response to the combination of SB, bFGF, and BMP4. Treatment with the three inducers during hepatic progenitor differentiation significantly enhanced the mRNA and protein levels of F-VIII and F-IX in ES cell–derived hepatocytes. More importantly, F-VIII and F-IX were coexpressed with high efficiency at the final stage of differentiation, and they were also secreted into the culture medium.
Conclusion:
We have established a novel in vitro differentiation protocol for ES-derived hepatocytes that coexpress F-VIII and F-IX that may provide a foundation for stem cell replacement therapy for hemophilia.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Accession codes
Accessions
GenBank/EMBL/DDBJ
References
Saenko EL, Ananyeva N, Kouiavskaia D, Schwinn H, Josic D, Shima M, et al. Molecular defects in coagulation Factor VIII and their impact on Factor VIII function. Vox Sang 2002; 83: 89–96.
Castaldo G, Nardiello P, Bellitti F, Santamaria R, Rocino A, Coppola A, et al. Haemophilia B: from molecular diagnosis to gene therapy. Clin Chem Lab Med 2003; 41: 445–51.
Bowen DJ . Haemophilia A and haemophilia B: molecular insights. Mol Pathol 2002; 55: 127–44.
Engelfriet CP RH . Prophylactic treatment of patients with haemophilia A or haemophilia B. Vox Sang 2005; 88: 62–7.
Bolton-Maggs PH . Optimal haemophilia care versus the reality. Br J Haematol 2006; 132: 671–82.
Ohashi K, Waugh JM, Dake MD, Yokoyama T, Kuge H, Nakajima Y, et al. Liver tissue engineering at extrahepatic sites in mice as a potential new therapy for genetic liver diseases. Hepatology 2005; 41: 132–40.
Prelle K, Zink N, Wolf E . Pluripotent stem cells — model of embryonic development, tool for gene targeting, and basis of cell therapy. Anat Histol Embryol 2002; 31: 169–86.
Kasuda S, Kubo A, Sakurai Y, Irion S, Ohashi K, Tatsumi K, et al. Establishment of embryonic stem cells secreting human factor VIII for cell-based treatment of hemophilia A. J Thromb Haemost 2008; 6: 1352–9.
Fair JH, Cairns BA, Lapaglia MA, Caballero M, Pleasant WA, Hatada S, et al. Correction of factor IX deficiency in mice by embryonic stem cells differentiated in vitro. Proc Natl Acad Sci USA 2005; 102: 2958–63.
Blouin MJ, Lamy I, Loranger A, Noel M, Corlu A, Guguen-Guillouzo C, et al. Specialization switch in differentiating embryonic rat liver progenitor cells in response to sodium butyrate. Exp Cell Res 1995; 217: 22–30.
McKiernan E, O'Driscoll L, Kasper M, Barron N, O'Sullivan F, Clynes M . Directed differentiation of mouse embryonic stem cells into pancreatic-like or neuronal- and glial-like phenotypes. Tissue Eng 2007; 13: 2419–30.
Min J, Shang CZ, Chen YJ, Zhang L, Liu L, Deng XG, et al. Selective enrichment of hepatocytes from mouse embryonic stem cells with a culture system containing cholestatic serum. Acta Pharmacol Sin 2007; 28: 1931–7.
Rambhatla L, Chiu CP, Kundu P, Peng Y, Carpenter MK . Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant 2003; 12: 1–11.
Sharma NS, Shikhanovich R, Schloss R, Yarmush ML . Sodium butyrate-treated embryonic stem cells yield hepatocyte-like cells expressing a glycolytic phenotype. Biotechnol Bioeng 2006; 94: 1053–63.
Zhou QJ, Xiang LX, Shao JZ, Hu RZ, Lu YL, Yao H, et al. In vitro differentiation of hepatic progenitor cells from mouse embryonic stem cells induced by sodium butyrate. J Cell Biochem 2007; 100: 29–42.
Czyz J, Wobus A . Embryonic stem cell differentiation: the role of extracellular factors. Differentiation 2001; 68: 167–74.
Schuldiner M, Yanuka O, Itskovitz-Eldor J, Melton DA, Benvenisty N . Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2000; 97: 11307–12.
Gouon-Evans V, Boussemart L, Gadue P, Nierhoff D, Koehler CI, Kubo A, et al. BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat Biotechnol 2006; 24: 1402–11.
Rossi JM, Dunn NR, Hogan BL, Zaret KS . Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. Genes Dev 2001; 15: 1998–2009.
Gong SG, Guo C . Bmp4 gene is expressed at the putative site of fusion in the midfacial region. Differentiation 2003; 71: 228–36.
Jung J, Zheng M, Goldfarb M, Zaret KS . Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science 1999; 284: 1998–2003.
Ishikawa T, Terai S, Urata Y, Marumoto Y, Aoyama K, Sakaida I, et al. Fibroblast growth factor 2 facilitates the differentiation of transplanted bone marrow cells into hepatocytes. Cell Tissue Res 2006; 323: 221–31.
Zhou QJ, Huang YD, Xiang LX, Shao JZ, Zhou GS, Yao H, et al. In vitro differentiation of embryonic stem cells into hepatocytes induced by fibroblast growth factors and bone morphological protein-4. Int J Biochem Cell Biol 2007; 39: 1714–21.
Ong SY, Dai H, Leong KW . Hepatic differentiation potential of commercially available human mesenchymal stem cells. Tissue Eng 2006; 12: 3477–85.
Soto-Gutierrez A, Kobayashi N, Rivas-Carrillo JD, Navarro-Alvarez N, Zhao D, Okitsu T, et al. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol 2006; 24: 1412–9.
Acknowledgements
This work was supported by grants from the China National Programs for High Technology Research and Development (No 2007AA02Z117), the National Natural Science Foundation of China (No 30571805 and 30672036), the Science and Technology project of Guang Dong province (No 2008B080703028), the Doctoral Fund of Youth Scholars of Ministry of Education of China (No 200805581132), and the China Postdoctoral Special Foundation.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Cao, J., Shang, Cz., Lü, Lh. et al. Differentiation of embryonic stem cells into hepatocytes that coexpress coagulation factors VIII and IX. Acta Pharmacol Sin 31, 1478–1486 (2010). https://doi.org/10.1038/aps.2010.100
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2010.100
Keywords
This article is cited by
-
Generation of an mESC model with a human hemophilia B nonsense mutation via CRISPR/Cas9 technology
Stem Cell Research & Therapy (2022)
-
CRISPR/Cas9-mediated gene correction in hemophilia B patient-derived iPSCs
International Journal of Hematology (2020)
